Recruiting Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease NCT07226219 Conditions Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +17 more Locations St. Jude Children's Research Hospital — Memphis, Tennessee, United States View Trial Details
Completed To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, Hard Lisdexamfetamine Dimesylate in Healthy, Adult, Human Subjects Under Fasting Conditions. NCT07098585 Conditions Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention Deficit/Hyperactivity Disorder (ADHD), +2 more Locations Cliantha Research Limited — Ahmedabad, Gujarat, India View Trial Details
Completed Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too) NCT02675400 Conditions Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention Deficit/Hyperactivity Disorder (ADHD), +8 more Locations Seattle Children's — Seattle, Washington, United States View Trial Details
Completed Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. NCT00399698 Conditions Adjustment Disorder, Adjustment Disorders, Attention Deficit Disorder with Hyperactivity, +15 more Locations Ohio State University Nisonger Center — Columbus, Ohio, United States View Trial Details
Completed The Efficacy and Safety of Phosphatidylserine-Omega3 in Children With Attention-Deficit/ Hyperactivity Disorder NCT00418184 Conditions Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention Deficit/Hyperactivity Disorder (ADHD), +10 more Locations ADHD Unit — Petach-Tiqva, Israel View Trial Details
